Network effects of the neuropsychiatric 15q13.3 microdeletion on the transcriptome and epigenome in human induced neurons
Siming ZhangiD, Xianglong ZhangiD, Carolin PurmanniD, Shining MaiD, Anima ShresthaiD, Kasey N. DavisiD, Marcus HoiD, Yi‐Ling HuangiD, Reenal PattniiD, Wing Hung WongiD, Jonathan Adam BernsteiniD, Joachim Franz HallmayeriD, Alexander Eckehart UrbaniD
Abstract
Heterozygous deletions in the 15q13.3 region are associated with several neuropsychiatric disorders including autism, schizophrenia, and attention deficit hyperactivity disorder. Several genes within the 15q13.3 deletion region may play a role in neuronal dysfunction, based on association studies in humans and functional studies in mice, but the intermediate molecular mechanisms remain unknown. We analyzed the genome-wide effects of the 15q13.3 microdeletion on the transcriptome and epigenome. Induced pluripotent stem cell (iPSC) lines from three patients with the typical heterozygous 15q13.3 microdeletion and three sex-matched controls were generated and converted into induced neurons (iNs) using the neurogenin-2 induction method. We analyzed genome-wide gene expression using RNA-Seq, genome-wide DNA methylation using SeqCap-Epi, and genome-wide chromatin accessibility using ATAC-Seq, in both iPSCs and iNs. In both cell types, gene copy number change within the 15q13.3 microdeletion was accompanied by significantly decreased gene expression and no compensatory changes in DNA methylation or chromatin accessibility, supporting the model that haploinsufficiency of genes within the deleted region drives the disorder. Further, we observed global effects of the deletion on the transcriptome and epigenome, with the effects being cell type specific and occurring at discrete loci. Several genes and pathways associated with neuropsychiatric disorders and neuronal development were significantly altered, including Wnt signaling, ribosome biogenesis, DNA binding, and clustered protocadherins. This molecular systems analysis of a large neuropsychiatric microdeletion can also be applied to other brain relevant chromosomal aberrations to further our etiological understanding of neuropsychiatric disorders.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 22
- FWCI
- 1.80
- Field percentile
- top 15%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Altered gene expression profiles impair the nervous system development in individuals with 15q13.3 microdeletion
Marek B. Körner, Akhil Velluva, … Diana Le Duc·Scientific ReportsPeer-reviewed·Aug 5, 2022
- Altered development and network connectivity in a human neuronal model of 15q11.2 deletion-related neurodevelopmental disorders
Christa Whelan Habela, Shiyu Liu, … Nicholas John Maragakis·Translational PsychiatryPeer-reviewed·Aug 29, 2025
- Loss-of-function of OTUD7A in the schizophrenia-associated 15q13.3 deletion impairs synapse development and function in human neurons
Alena Kozlova, Siwei Zhang, … Jubao Duan·The American Journal of Human GeneticsPeer-reviewed·Aug 1, 2022
- Direct induction of human neurons from fibroblasts carrying the neuropsychiatric 22q11.2 microdeletion reveals transcriptome- and epigenome-wide alterations
Carolin Purmann, Cheen Euong Ang, … Alexander Eckehart Urban·bioRxiv·Oct 14, 2021
- Alterations in neuronal physiology, development, and function associated with a common duplication of chromosome 15 involving CHRNA7
Kesavan Meganathan, Ramachandran Prakasam, … Kristen L. Kroll·BMC BiologyPeer-reviewed·Jul 28, 2021
- The 16p11.2 microdeletion enhances gene expression variability between human IPSC derived forebrain interneuron progenitor cells in culture.
Yifei Yang, Idoia Quintana Urzainqui, Thomas Pratt·Frontiers in Molecular NeurosciencePeer-reviewed·Jul 8, 2026